-
1.发明公开公开(公告)号：US20240082322A1
公开(公告)日：2024-03-14
申请号：US18299197
申请日：2023-04-12
发明人： Yuejian Mao , Markus Lehtinen
IPC分类号： A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24
CPC分类号： A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24 , A61K9/19
摘要： The invention relates to compositions comprising Lactobacillus plantarum, and methods and uses of said compositions for preventing and/or treating mental illness, symptoms affecting mental health and/or conditions associated with chronic stress, in a mammal. The invention can be applied in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of dietary and food supplements, medicaments and pharmaceuticals.
-
公开(公告)号：US20230380471A1
公开(公告)日：2023-11-30
申请号：US18248077
申请日：2021-10-08
发明人： Sile Griffin , Elaine Patterson , Markus Lehtinen
IPC分类号： A23L33/135 , A61K35/744 , A61P25/28
CPC分类号： A23L33/135 , A61K35/744 , A61P25/28 , A61K2035/115
摘要： This invention relates to bacteria of the species Lacticaseibacillus paracasei for use in preventing or treating cognitive impairments in a subject in need thereof. This invention also relates to bacteria of the species Lacticaseibacillus paracasei for use in preventing or treating cognitive impairments induced by sleep deprivation and/or insufficient sleep in a subject in need thereof.
-
公开(公告)号：US20200330531A1
公开(公告)日：2020-10-22
申请号：US16954590
申请日：2018-12-18
发明人： Lotta Stenman , Markus Lehtinen
IPC分类号： A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24
摘要： The invention relates to bacteria of the species Lactobacillus paracasei and/or compositions comprising Lactobacillus paracasei for use in preventing and/or treating a mental illness, a symptom affecting mental health and/or a condition associated with chronic stress, in a mammal. The invention further relates to methods and uses of said bacteria of the species Lactobacillus paracasei and/or compositions. The invention can be applied in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of dietary and food supplements, medicaments and pharmaceuticals.
-
公开(公告)号：US20240108668A1
公开(公告)日：2024-04-04
申请号：US18257612
申请日：2021-12-13
发明人： Maija Emilia Marttinen , Markku Saarinen , Arja Laitila , Paivi Nurminen , Markus Lehtinen , Mehreen Anjum
IPC分类号： A61K35/747 , A23L33/135 , A23L33/185 , A61K35/744 , A61K35/745 , A61P1/14
CPC分类号： A61K35/747 , A23L33/135 , A23L33/185 , A61K35/744 , A61K35/745 , A61P1/14 , A23V2400/113 , A23V2400/231 , A23V2400/531 , A61K2035/115
摘要： This invention relates to the use of bacterial strains for improving protein digestion and/or increasing amino acid bioavailability in a subject, wherein said bacterial strains are of the species Bifidobacterium animalis subsp. lactis, Lacticaseibacillus paracasei, Lactococcus lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and/or Lacticaseibacillus rhamnosus or a mixture thereof.
-
公开(公告)号：US11883446B2
公开(公告)日：2024-01-30
申请号：US17711081
申请日：2022-04-01
发明人： Sebastien Guery , Markus Lehtinen , Sinikka Anneli Latvala , Liisa Lehtoranta , Bryan-James Zabel , Wesley William Morovic , Charles Budinoff , Scott D. Power
IPC分类号： A61K35/745 , A61P31/14 , A61K35/744
CPC分类号： A61K35/745 , A61K35/744 , A61P31/14
摘要： This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
-
公开(公告)号：US20230277608A1
公开(公告)日：2023-09-07
申请号：US17937090
申请日：2022-09-30
发明人： Lotta Stenman , Markus Lehtinen
IPC分类号： A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24
CPC分类号： A61K35/747 , A23L33/135 , A61P25/22 , A61P25/24 , A23Y2220/63 , A23Y2220/67
摘要： The invention relates to bacteria of the species Lactobacillus paracasei and/or compositions comprising Lactobacillus paracasei for use in preventing and/or treating a mental illness, a symptom affecting mental health and/or a condition associated with chronic stress, in a mammal. The invention further relates to methods and uses of said bacteria of the species Lactobacillus paracasei and/or compositions. The invention can be applied in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of dietary and food supplements, medicaments and pharmaceuticals.
-
7.发明申请公开(公告)号：US20220143113A1
公开(公告)日：2022-05-12
申请号：US16954622
申请日：2018-01-18
发明人： Yuejian Mao , Markus Lehtinen
IPC分类号： A61K35/747 , A61P25/22 , A61P25/24 , A23L33/135
摘要： A composition comprising Lactobacillus plantarum for preventing and/or treating mental illness, symptoms affecting mental health and/or conditions associated with chronic stress in a mammal is disclosed. The composition can be used in restoring, maintaining, and/or promoting mental (including cognitive) health and has potential applications, inter alia, in the area of a dietary and food supplement and a medicament.
-
公开(公告)号：US10668117B2
公开(公告)日：2020-06-02
申请号：US15544989
申请日：2016-01-27
IPC分类号： A61K35/745 , A61P11/00 , A23L33/135 , A61P31/12 , G01N33/569
摘要： The present invention relates to composition derivable from a bifidobacteria, methods and uses thereof, for use in modulating the immune system in a subject by affecting viral action and/or viral effects in said subject. Furthermore, said composition may also be used in reducing the risk of development and exacerbation of chronic respiratory diseases such as asthma and COPD in a subject; preferably by modulating the immune system in the subject by affecting viral action and/or viral effects in said subject.
-
9.发明公开公开(公告)号：US20240108667A1
公开(公告)日：2024-04-04
申请号：US18257603
申请日：2021-12-13
发明人： Maija Emilia Marttinen , Markku Saarinen , Arja Laitila , Paivi Nurminen , Markus Lehtinen , Mehreen Anjum
IPC分类号： A61K35/747 , A23L33/135 , A23L33/185 , A61K35/744 , A61K35/745 , A61P1/14
CPC分类号： A61K35/747 , A23L33/135 , A23L33/185 , A61K35/744 , A61K35/745 , A61P1/14 , A23V2400/113 , A23V2400/231 , A23V2400/531 , A61K2035/115
摘要： This invention relates to the use of bacterial strains for breaking down protein and increasing amino acid and peptide availability, wherein said bacterial strains are of the species Bifidobacterium animalis subsp. lactis, Lacticaseibacillus paracasei, Lactococcus lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and/or Lacticaseibacillus rhamnosus or a mixture thereof.
-
10.发明申请公开(公告)号：US20220370519A1
公开(公告)日：2022-11-24
申请号：US17711081
申请日：2022-04-01
发明人： Sebastien Guery , Markus Lehtinen , Sinikka Anneli Latvala , Liisa Lehtoranta , Bryan-James Zabel , Wesley William Morovic , Charles Budinoff , Scott D. Power
IPC分类号： A61K35/745 , A61P31/14 , A61K35/744
摘要： This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
-
-
-
-
-
-
-
-
-
搜索结果
13 条记录 (耗时 0.016 秒)
